Skip to main content
Top
Published in: BMC Emergency Medicine 1/2023

Open Access 01-12-2023 | Tramadol | Research

Assessment of renal function indexes in methamphetamine or tramadol intoxication adults to the emergency departments: a systematic review and meta-analysis

Authors: Alireza Amanollahi, Yadollah Mehrabi, Mohsen Sedighi, Hamed Basir Ghafouri, Amir Zahedi, Shahin Shadnia, Koorosh Etemad

Published in: BMC Emergency Medicine | Issue 1/2023

Login to get access

Abstract

Background

Renal dysfunction is one of the adverse effects observed in methamphetamine (MET) or tramadol abusers. In this study, we aimed to review articles involving intoxication with MET or tramadol to assess the occurrence of renal dysfunction.

Methods

Two researchers systematically searched PubMed, Scopus, Web of Sciences, and Google Scholar databases from 2000 to 2022. All articles that assessed renal function indexes including creatine, Blood Urea Nitrogen (BUN), and Creatine phosphokinase (CPK) in MET and tramadol intoxication at the time of admission in hospitals were included. We applied random effect model with Knapp-Hartung adjustment for meta-analysis using STATA.16 software and reported outcomes with pooled Weighted Mean (WM).

Results

Pooled WM for BUN was 29.85 (95% CI, 21.25–38.46) in tramadol intoxication and 31.64(95% CI, 12.71–50.57) in MET intoxication. Pooled WM for creatinine in tramadol and MET intoxication was respectively 1.04 (95% CI, 0.84–1.25) and 1.35 (95% CI, 1.13–1.56). Also, pooled WM for CPK was 397.68(376.42-418.94) in tramadol and 909.87(549.98-1269.76) in MET intoxication. No significance was observed in publication bias and heterogeneity tests.

Conclusion

Our findings showed that tramadol or MET intoxication is associated with a considerably increased risk of renal dysfunction that may result in organ failure.
Literature
1.
go back to reference Mokhtari T, Sheikhazadi A, Hassanzadeh G, Safari M, Sheikhbahaei F, Faghir-Ghanesefat H, et al. Potential adverse effects of amphetamines on kidney; a narrative review on current knowledge. J Ren Injury Prev. 2018;7(4):218–23.CrossRef Mokhtari T, Sheikhazadi A, Hassanzadeh G, Safari M, Sheikhbahaei F, Faghir-Ghanesefat H, et al. Potential adverse effects of amphetamines on kidney; a narrative review on current knowledge. J Ren Injury Prev. 2018;7(4):218–23.CrossRef
2.
go back to reference Weng T-I, Chen H-Y, Chin LW, Chou H-H, Wu M-H, Chen G-y et al. Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department. Clin Toxicol. 2022;1–7. Weng T-I, Chen H-Y, Chin LW, Chou H-H, Wu M-H, Chen G-y et al. Comparison of clinical characteristics between meth/amphetamine and synthetic cathinone users presented to the emergency department. Clin Toxicol. 2022;1–7.
3.
go back to reference Schep LJ, Slaughter RJ, Beasley DMG. The clinical toxicology of metamfetamine. Clin Toxicol. 2010;48(7):675–94.CrossRef Schep LJ, Slaughter RJ, Beasley DMG. The clinical toxicology of metamfetamine. Clin Toxicol. 2010;48(7):675–94.CrossRef
4.
go back to reference Ago M, Ago K, Hara K, Kashimura S, Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg Med. 2006;8(4):235–9.CrossRef Ago M, Ago K, Hara K, Kashimura S, Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg Med. 2006;8(4):235–9.CrossRef
5.
go back to reference Richards JR, Laurin EG. Methamphetamine toxicity. StatPearls [Internet]: StatPearls Publishing; 2021. Richards JR, Laurin EG. Methamphetamine toxicity. StatPearls [Internet]: StatPearls Publishing; 2021.
6.
go back to reference Nakhaee S, Amirabadizadeh A, Brent J, Miri-Moghaddam E, Foadoddini M, Farrokhfall K, et al. Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Crit Rev Toxicol. 2019;49(8):710–23.CrossRefPubMed Nakhaee S, Amirabadizadeh A, Brent J, Miri-Moghaddam E, Foadoddini M, Farrokhfall K, et al. Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Crit Rev Toxicol. 2019;49(8):710–23.CrossRefPubMed
7.
go back to reference Ahmadimanesh M, Shadnia S, Rouini MR, Sheikholeslami B, Nasab SA, Ghazi-Khansari M. Correlation between plasma concentrations of tramadol and its metabolites and the incidence of seizure in tramadol-intoxicated patients. Drug Metabolism and Personalized Therapy. 2018;33(2):75–83.CrossRefPubMed Ahmadimanesh M, Shadnia S, Rouini MR, Sheikholeslami B, Nasab SA, Ghazi-Khansari M. Correlation between plasma concentrations of tramadol and its metabolites and the incidence of seizure in tramadol-intoxicated patients. Drug Metabolism and Personalized Therapy. 2018;33(2):75–83.CrossRefPubMed
8.
go back to reference Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol. 2010;48(4):337–41.CrossRef Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol. 2010;48(4):337–41.CrossRef
9.
go back to reference Afshari R, Tashakori A, Shakiba A, editors. Tramadol overdose induced CPK rise, haemodynamic and electocardiographic changes and seizure. Clinical toxicology. New York: Informa Healthcare.Vanderbilt Ave; 2008. Ny 10017 Usa. Afshari R, Tashakori A, Shakiba A, editors. Tramadol overdose induced CPK rise, haemodynamic and electocardiographic changes and seizure. Clinical toxicology. New York: Informa Healthcare.Vanderbilt Ave; 2008. Ny 10017 Usa.
10.
go back to reference Habibollahi P, Garjani A, Vahdati SS, Seyyed-Reza SE, Parnianfard N, Zakeri R. Characteristics of patients with tramadol use or abuse: a systematic review and Meta-analysis. Eurasian J Emerg Med. 2020;19(3):127.CrossRef Habibollahi P, Garjani A, Vahdati SS, Seyyed-Reza SE, Parnianfard N, Zakeri R. Characteristics of patients with tramadol use or abuse: a systematic review and Meta-analysis. Eurasian J Emerg Med. 2020;19(3):127.CrossRef
11.
go back to reference Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci. 2005;30(2):245–52.CrossRefPubMed Atici S, Cinel I, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci. 2005;30(2):245–52.CrossRefPubMed
12.
go back to reference Mohammadpour A, Ashkezari MD, Farahmand B, Shokrzadeh M. Demographic characteristics and functional performance of the kidneys and hearts of patients with acute tramadol toxicity. Drug Res. 2019;69(04):207–10.CrossRef Mohammadpour A, Ashkezari MD, Farahmand B, Shokrzadeh M. Demographic characteristics and functional performance of the kidneys and hearts of patients with acute tramadol toxicity. Drug Res. 2019;69(04):207–10.CrossRef
13.
14.
go back to reference Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid synthesis. 2020;18(10):2127–33. Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid synthesis. 2020;18(10):2127–33.
15.
go back to reference Jackson D, Law M, Rücker G, Schwarzer G. The Hartung-Knapp modification for random‐effects meta‐analysis: a useful refinement but are there any residual concerns? Stat Med. 2017;36(25):3923–34.CrossRefPubMedPubMedCentral Jackson D, Law M, Rücker G, Schwarzer G. The Hartung-Knapp modification for random‐effects meta‐analysis: a useful refinement but are there any residual concerns? Stat Med. 2017;36(25):3923–34.CrossRefPubMedPubMedCentral
16.
go back to reference Schünemann H, Brożek J, Guyatt G, Oxman A. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October. 2013;2013. Schünemann H, Brożek J, Guyatt G, Oxman A. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October. 2013;2013.
17.
go back to reference Bahrami-Motlagh H, Hassanian-Moghaddam H, Zamini H, Zamani N, Gachkar L. Correlation of abdominopelvic computed tomography with clinical manifestations in methamphetamine body stuffers. Radiol Med. 2018;123(2):98–104.CrossRefPubMed Bahrami-Motlagh H, Hassanian-Moghaddam H, Zamini H, Zamani N, Gachkar L. Correlation of abdominopelvic computed tomography with clinical manifestations in methamphetamine body stuffers. Radiol Med. 2018;123(2):98–104.CrossRefPubMed
18.
go back to reference Rahimi M, Lookzadeh S, Sadeghi R, Soltaninejad K, Shadnia S, Pajoumand A et al. Predictive factors of mortality in acute amphetamine type stimulants poisoning; a review of 226 cases. Emergency. 2018;6(1). Rahimi M, Lookzadeh S, Sadeghi R, Soltaninejad K, Shadnia S, Pajoumand A et al. Predictive factors of mortality in acute amphetamine type stimulants poisoning; a review of 226 cases. Emergency. 2018;6(1).
19.
go back to reference Rahimi HR, Soltaninejad K, Shadnia S. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med sciences: official J Isfahan Univ Med Sci. 2014;19(9):855. Rahimi HR, Soltaninejad K, Shadnia S. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med sciences: official J Isfahan Univ Med Sci. 2014;19(9):855.
20.
go back to reference Richards JR, Wang CG, Fontenette RW, Stuart RP, McMahon KF, Turnipseed SD. Rhabdomyolysis, methamphetamine, amphetamine and MDMA use: Associated factors and risks. J Dual Diagnosis. 2020;16(4):429–37.CrossRef Richards JR, Wang CG, Fontenette RW, Stuart RP, McMahon KF, Turnipseed SD. Rhabdomyolysis, methamphetamine, amphetamine and MDMA use: Associated factors and risks. J Dual Diagnosis. 2020;16(4):429–37.CrossRef
21.
go back to reference Isoardi KZ, Mudge DW, Harris K, Dimeski G, Buckley NA. Methamphetamine intoxication and acute kidney injury: a prospective observational case series. Nephrology. 2020;25(10):758–64.CrossRefPubMed Isoardi KZ, Mudge DW, Harris K, Dimeski G, Buckley NA. Methamphetamine intoxication and acute kidney injury: a prospective observational case series. Nephrology. 2020;25(10):758–64.CrossRefPubMed
22.
go back to reference Suriyaprom K, Tanateerabunjong R, Tungtrongchitr A, Tungtrongchitr R. Alterations in malondialdehyde levels and laboratory parameters among methamphetamine abusers. J Med Association Thailand = Chotmaihet thangphaet. 2011;94(12):1533–9. Suriyaprom K, Tanateerabunjong R, Tungtrongchitr A, Tungtrongchitr R. Alterations in malondialdehyde levels and laboratory parameters among methamphetamine abusers. J Med Association Thailand = Chotmaihet thangphaet. 2011;94(12):1533–9.
23.
go back to reference Ismail MA, Mahmoud SF, Khedr MA, Mohammed MK. Assessment of cases of Acute Tramadol Toxicity as Regards Clinical, Laboratory and Management Procedures in some University Hospitals in Cairo. Egypt J Hosp Med. 2018;72(1). Ismail MA, Mahmoud SF, Khedr MA, Mohammed MK. Assessment of cases of Acute Tramadol Toxicity as Regards Clinical, Laboratory and Management Procedures in some University Hospitals in Cairo. Egypt J Hosp Med. 2018;72(1).
25.
go back to reference Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 2006;1(6):1314–9.CrossRefPubMed Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 2006;1(6):1314–9.CrossRefPubMed
26.
go back to reference Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33(3):409–13.CrossRefPubMed Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33(3):409–13.CrossRefPubMed
27.
go back to reference van Meer L, Moerland M, Cohen AF, Burggraaf J. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol. 2014;77(6):947–57.CrossRefPubMed van Meer L, Moerland M, Cohen AF, Burggraaf J. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol. 2014;77(6):947–57.CrossRefPubMed
29.
go back to reference Bhattacharyya K, Phaujdar S, Sarkar R, Mullick OS. Serum creatine phosphokinase: a probable marker of severity in organophosphorus poisoning. Toxicol Int. 2011;18(2):117–23.CrossRefPubMedPubMedCentral Bhattacharyya K, Phaujdar S, Sarkar R, Mullick OS. Serum creatine phosphokinase: a probable marker of severity in organophosphorus poisoning. Toxicol Int. 2011;18(2):117–23.CrossRefPubMedPubMedCentral
30.
go back to reference Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010;48(6):749–56.CrossRefPubMed Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010;48(6):749–56.CrossRefPubMed
31.
go back to reference Zutt R, Van Der Kooi A, Linthorst G, Wanders R, De Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24(8):651–9.CrossRefPubMed Zutt R, Van Der Kooi A, Linthorst G, Wanders R, De Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014;24(8):651–9.CrossRefPubMed
32.
go back to reference Pajoum A, Fahim F, Akhlaghdoust M, Zamani N, Amirfirooz Z, Dehdehasti M. Rhabdomyolysis and Acute Poisoning; a brief report. Emerg. 2018;6(1):e56–e. Pajoum A, Fahim F, Akhlaghdoust M, Zamani N, Amirfirooz Z, Dehdehasti M. Rhabdomyolysis and Acute Poisoning; a brief report. Emerg. 2018;6(1):e56–e.
33.
go back to reference Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.CrossRefPubMed Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.CrossRefPubMed
35.
go back to reference Nakhaee S, Hoyte C, Dart RC, Askari M, Lamarine RJ, Mehrpour O. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicol. 2021;39(2):293–310.CrossRef Nakhaee S, Hoyte C, Dart RC, Askari M, Lamarine RJ, Mehrpour O. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicol. 2021;39(2):293–310.CrossRef
36.
go back to reference Mehrpour O, Sharifi M, Zamani N. Tramadol poisoning. In: Andreazza AC, Scola G, editors. Toxicology studies cells, drugs and environment. BoD, Books on Demand; 2015. Mehrpour O, Sharifi M, Zamani N. Tramadol poisoning. In: Andreazza AC, Scola G, editors. Toxicology studies cells, drugs and environment. BoD, Books on Demand; 2015.
Metadata
Title
Assessment of renal function indexes in methamphetamine or tramadol intoxication adults to the emergency departments: a systematic review and meta-analysis
Authors
Alireza Amanollahi
Yadollah Mehrabi
Mohsen Sedighi
Hamed Basir Ghafouri
Amir Zahedi
Shahin Shadnia
Koorosh Etemad
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Emergency Medicine / Issue 1/2023
Electronic ISSN: 1471-227X
DOI
https://doi.org/10.1186/s12873-023-00855-1

Other articles of this Issue 1/2023

BMC Emergency Medicine 1/2023 Go to the issue